![Arthur M. Krieg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Arthur M. Krieg
Former positions of Arthur M. Krieg
Companies | Position | Start | End |
---|---|---|---|
CHECKMATE PHARMACEUTICALS, INC. | Director/Board Member | 2015-06-30 | - |
Chief Executive Officer | 2015-06-30 | 2018-12-11 | |
Chief Tech/Sci/R&D Officer | 2018-12-11 | 2022-09-30 | |
Founder | 2015-06-30 | 2022-09-30 | |
President | 2015-06-30 | - | |
SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2014-01-08 | 2014-07-21 |
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Director/Board Member | 2012-03-20 | 2014-05-30 |
TRANSLATE BIO, INC. | Chief Executive Officer | 2011-05-31 | 2013-12-31 |
TRANSLATE BIO, INC. | Chief Executive Officer | 2010-12-31 | 2012-12-31 |
Founder | 2010-12-31 | 2012-12-31 | |
Coley Pharmaceutical Group, Inc.
![]() Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Chief Tech/Sci/R&D Officer | 1997-04-30 | 2011-05-02 |
Founder | 1997-04-30 | 2011-05-02 | |
Oligonucleotide Therapeutics Society, Inc.
![]() Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Chief Tech/Sci/R&D Officer | 2007-12-31 | - |
National Institute of Arthritis | Corporate Officer/Principal | - | - |
University of Iowa | Corporate Officer/Principal | 1999-03-31 | - |
Training of Arthur M. Krieg
Haverford College | Undergraduate Degree |
University of Washington | Doctorate Degree |
Statistics
International
United States | 10 |
Switzerland | 2 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Founder | 3 |
Chief Executive Officer | 3 |
Sectoral
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
Coley Pharmaceutical Group, Inc.
![]() Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
National Institute of Arthritis | Government |
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Oligonucleotide Therapeutics Society, Inc.
![]() Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
Checkmate Pharmaceuticals, Inc.
![]() Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
Translate Bio, Inc.
![]() Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Arthur M. Krieg
- Experience